Inspire Medical Systems (NYSE:INSP – Get Free Report) was upgraded by equities research analysts at Barclays to a “strong sell” rating in a research report issued to clients and investors on Tuesday, Zacks reports. INSP has been the topic of a number of other reports. Zacks Research downgraded shares of Inspire Medical Systems from a […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.